Related Experiment Video
Updated: Mar 7, 2026

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
Published on: February 15, 2022
Epitranscriptomic Control of Vascular Smooth Muscle Cell Ferroptosis by WTAP in the Pathogenesis of Vascular
Yanwei Yin1, Fangmeng Lei1, Zihe Dang1
1Department of Cardiology, Wuxi No.2 People's Hospital, Wuxi, China.
Aims:
Vascular restenosis is a common complication following vascular interventions, driven by abnormal proliferation and phenotypic switching of vascular smooth muscle cells (VSMCs). Ferroptosis, an iron-dependent regulated cell death, has been implicated in VSMC dysfunction and vascular remodeling. However, the epitranscriptomic regulation of ferroptosis in VSMCs remains unclear.This study investigates the role of Wilms tumor suppressor gene WT1-associated protein (WTAP), a key N6-methyladenosine (m6A) RNA methylation regulator, in controlling ferroptosis of VSMCs during vascular restenosis.
Results:
A balloon injury rat model and platelet-derived growth factor-BB-stimulated VSMCs were used to mimic vascular restenosis. WTAP expression and global m6A levels were assessed. Functional assays evaluated the effects of WTAP overexpression on ferroptosis markers, reactive oxygen species (ROS), lipid peroxidation, and VSMC proliferation. Mechanistic studies explored WTAP-mediated m6A modification of the long non-coding RNA growth arrest specific 5 (GAS5), its interaction with enhancer of zeste 2 polycomb repressive complex 2 subunit (EZH2), and downstream regulation of interferon regulatory factor 4 (IRF4) and ferritin heavy chain 1 (FTH1).WTAP expression and global m6A levels were significantly reduced in restenotic tissues and cells. WTAP overexpression restored m6A modification on GAS5, enhancing its stability via YTH domain family member 1. GAS5 inhibited EZH2-mediated H3K27me3 repression of IRF4, which transcriptionally activated FTH1, suppressing ferroptosis. WTAP overexpression decreased ROS, lipid peroxidation, and VSMC proliferation, while knockdown of GAS5 or IRF4 partially reversed these effects.
Innovation:
Our study is the first to identify that the WTAP/GAS5/IRF4 axis suppresses PDGF-BB-induced cell proliferation by inhibiting ferroptosis in VSMCs, and alleviates vascular restenosis caused by balloon injury.
Conclusion:
WTAP epitranscriptomically regulates VSMC ferroptosis via the GAS5/EZH2/IRF4/FTH1 axis, revealing a novel mechanism in vascular restenosis pathogenesis and a potential therapeutic target. Antioxid. Redox Signal. 44, 726-747.
Insights
Wilms tumor suppressor gene WT1-associated protein (WTAP) regulates vascular smooth muscle cell (VSMC) ferroptosis via the GAS5/EZH2/IRF4/FTH1 pathway. This finding reveals a novel mechanism in vascular restenosis and offers a potential therapeutic target.
Area of Science:
- Cardiovascular Biology
- Epigenetics
- Cell Death Mechanisms
Background:
- Vascular restenosis is a significant complication post-intervention, characterized by vascular smooth muscle cell (VSMC) proliferation and phenotypic changes.
- Ferroptosis, a form of regulated cell death, contributes to VSMC dysfunction and vascular remodeling, but its epitranscriptomic regulation is not well understood.
- N6-methyladenosine (m6A) RNA methylation, regulated by Wilms tumor gene WT1-associated protein (WTAP), plays a role in cellular processes, yet its function in VSMC ferroptosis remains unexplored.
Purpose of the Study:
- To investigate the role of WTAP in regulating ferroptosis of VSMCs in the context of vascular restenosis.
- To elucidate the molecular mechanisms by which WTAP controls VSMC ferroptosis and proliferation.
Main Methods:
- Vascular restenosis was modeled using a balloon injury rat model and platelet-derived growth factor-BB (PDGF-BB)-stimulated VSMCs.
- WTAP expression, global m6A levels, ferroptosis markers, reactive oxygen species (ROS), and lipid peroxidation were assessed.
- Mechanistic studies focused on WTAP-mediated m6A modification of long non-coding RNA GAS5, its interaction with EZH2, and downstream effects on IRF4 and FTH1.
Main Results:
- WTAP expression and m6A levels were reduced in restenotic tissues and cells.
- WTAP overexpression stabilized GAS5, which inhibited EZH2-mediated repression of IRF4, leading to increased FTH1 and suppressed ferroptosis.
- WTAP overexpression reduced ROS, lipid peroxidation, and VSMC proliferation, effects partially reversed by GAS5 or IRF4 knockdown.
Conclusions:
- WTAP epitranscriptomically regulates VSMC ferroptosis through the GAS5/EZH2/IRF4/FTH1 axis.
- This pathway represents a novel mechanism in vascular restenosis pathogenesis.
- The WTAP-mediated regulation of ferroptosis presents a potential therapeutic target for vascular restenosis.
More Related Videos
04:01Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
06:14Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function
Published on: June 11, 2017
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Vascular Spasm
Autoregulation of Blood Flow
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....